Stock & Company Details
CytomX Therapeutics Inc $CTMX
Price:
N/A
N/A
218M
$538M
52 Week High:
N/A
10 Day Average Volume:
N/A
-7.13
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CTMX technical indicators
Latest CytomX Therapeutics Inc (CTMX) indicator readings as of 2026-10-09.
CTMX's 14-day RSI is 36.4, in neutral territory. At $2.57 it is trading 36.0% below its 200-day moving average of $4.02, and below its 50-day average of $3.13. Price sits in the middle of its Bollinger Bands ($2.40 to $3.03). ADX reads 28.5, indicating a trending market.
Overview
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Finance Bot
Ask your questions
Start by typing a question below.
